v3.26.1
Condensed Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series C Convertible Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2024   $ 13,578 $ 29,801 $ 52,847          
Beginning Balance, Shares at Dec. 31, 2024   4,902,814 4,335,051 4,890,123          
Beginning Balance at Dec. 31, 2024 $ (70,630)         $ 541   $ (71,171)  
Beginning Balance, Shares at Dec. 31, 2024         4,139,219        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock             $ 600    
Beginning Balance at Dec. 31, 2024   $ 13,578 $ 29,801 $ 52,847          
Beginning Balance, Shares at Dec. 31, 2024   4,902,814 4,335,051 4,890,123          
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series C convertible preferred stock       $ 12,503          
Issuance of Series C convertible preferred stock, Shares       1,117,743          
Ending Balance at Mar. 31, 2025   $ 13,578 $ 29,801 $ 65,350          
Ending Balance, Shares at Mar. 31, 2025   4,902,814 4,335,051 6,007,866          
Beginning Balance at Dec. 31, 2024 (70,630)         541   (71,171)  
Beginning Balance, Shares at Dec. 31, 2024         4,139,219        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Deemed dividend related to issuance of Series C convertible preferred stock (584)         (584)      
Vesting of early exercised stock options 10         10      
Vesting of early exercised stock options, Shares         8,960        
Exercise of vested stock options 149         149      
Exercise of vested stock options, Shares         422,364        
Stock-based compensation expense 175         175      
Net loss (5,729)             (5,729)  
Ending Balance at Mar. 31, 2025 (76,609)         291   (76,900)  
Ending Balance, Shares at Mar. 31, 2025         4,570,543        
Beginning Balance at Dec. 31, 2024   $ 13,578 $ 29,801 $ 52,847          
Beginning Balance, Shares at Dec. 31, 2024   4,902,814 4,335,051 4,890,123          
Ending Balance at Jun. 30, 2025   $ 13,578 $ 29,801 $ 65,350          
Ending Balance, Shares at Jun. 30, 2025   4,902,814 4,335,051 6,007,866          
Beginning Balance at Dec. 31, 2024 (70,630)         541   (71,171)  
Beginning Balance, Shares at Dec. 31, 2024         4,139,219        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (12,495)                
Ending Balance at Jun. 30, 2025 (83,073)         593   (83,666)  
Ending Balance, Shares at Jun. 30, 2025         4,603,756        
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series C convertible preferred stock, Shares       1,117,743          
Beginning Balance at Mar. 31, 2025   $ 13,578 $ 29,801 $ 65,350          
Beginning Balance, Shares at Mar. 31, 2025   4,902,814 4,335,051 6,007,866          
Ending Balance at Jun. 30, 2025   $ 13,578 $ 29,801 $ 65,350          
Ending Balance, Shares at Jun. 30, 2025   4,902,814 4,335,051 6,007,866          
Beginning Balance at Mar. 31, 2025 (76,609)         291   (76,900)  
Beginning Balance, Shares at Mar. 31, 2025         4,570,543        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Vesting of early exercised stock options 10         10      
Vesting of early exercised stock options, Shares         8,960        
Exercise of vested stock options 34         34      
Exercise of vested stock options, Shares         24,253        
Stock-based compensation expense 258         258      
Net loss (6,766)             (6,766)  
Ending Balance at Jun. 30, 2025 (83,073)         593   (83,666)  
Ending Balance, Shares at Jun. 30, 2025         4,603,756        
Ending Balance at Mar. 31, 2026   $ 0 $ 0 $ 0          
Ending Balance, Shares at Mar. 31, 2026   0 0 0          
Beginning Balance at Dec. 31, 2025 $ 98,869         199,674   (100,805)  
Beginning Balance, Shares at Dec. 31, 2025 26,604,505       26,604,505        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Vesting of early exercised stock options $ 10         10      
Vesting of early exercised stock options, Shares         8,961        
Exercise of vested stock options 436         436      
Cashless exercise of warrants         30,366        
Exercise of vested stock options, Shares         537,669        
Stock-based compensation expense 1,629         1,629      
Net loss (8,696)             (8,696)  
Ending Balance at Mar. 31, 2026 92,248         201,749   (109,501)  
Ending Balance, Shares at Mar. 31, 2026         27,181,501        
Ending Balance at Jun. 30, 2026   $ 0 $ 0 $ 0          
Ending Balance, Shares at Jun. 30, 2026   0 0 0          
Beginning Balance at Dec. 31, 2025 $ 98,869         199,674   (100,805)  
Beginning Balance, Shares at Dec. 31, 2025 26,604,505       26,604,505        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of vested stock options, Shares 547,688                
Net loss $ (19,206)                
Ending Balance at Jun. 30, 2026 $ 84,246         204,274   (120,011) $ (17)
Ending Balance, Shares at Jun. 30, 2026 27,225,759       27,225,759        
Beginning Balance at Mar. 31, 2026   $ 0 $ 0 $ 0          
Beginning Balance, Shares at Mar. 31, 2026   0 0 0          
Ending Balance at Jun. 30, 2026   $ 0 $ 0 $ 0          
Ending Balance, Shares at Jun. 30, 2026   0 0 0          
Beginning Balance at Mar. 31, 2026 $ 92,248         201,749   (109,501)  
Beginning Balance, Shares at Mar. 31, 2026         27,181,501        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Vesting of early exercised stock options 11         11      
Vesting of early exercised stock options, Shares         8,961        
Exercise of vested stock options 36         36      
Exercise of vested stock options, Shares         10,019        
Issuance of common stock in connection with the employee stock purchase plan, Shares         25,278        
Issuance of common stock in connection with the employee stock purchase plan, Value 207         207      
Stock-based compensation expense 2,271         2,271      
Other comprehensive loss (17)               (17)
Net loss (10,510)             (10,510)  
Ending Balance at Jun. 30, 2026 $ 84,246         $ 204,274   $ (120,011) $ (17)
Ending Balance, Shares at Jun. 30, 2026 27,225,759       27,225,759